openPR Logo
Press release

What's driving the Contraceptive Devices Market Growth? Prominent Players: Bayer Pharmaceuticals,Pfizer, The Janssen Pharmaceutical Companies of John, Teva Pharmaceuticals, Merck, Mylan,Allergan, RECKITT BENCKISER GROUP PLCVeru Inc., Medisafe® Medication

What's driving the Contraceptive Devices Market Growth?

Several private institutions and government organizations are actively participating to spread awareness on the use of contraceptives. This, as per Fortune Business Insights is the chief driver of the global contraceptives devices market.

Sample PDF Brochure@ https://www.fortunebusinessinsights.com/enquiry/sample/contraceptive-devices-market-100062

Fortune Business Insights in a new report, titled “Contraceptives Devices Market: Global Market Analysis, Insights and Forecast, 2018-2025” predicts the market to exhibit a CAGR of 6.0%. The report further calculated the value of the contraceptives devices market as US$ 7013.8 Mn in the year 2018 and expected the market to reach US$ 11166.4 Mn by 2025.
Contraceptives devices for female are expected to lead the contraceptives devices market during the forecast period. Contraceptive devices for female are available in different types, among which the report emphasizes on the rising uptake of intrauterine contraceptive devices. Some of these include diaphragms & sponges, vaginal rings, sub-dermal implants, and female condoms.
Consequently, the sales of female contraceptive devices are accelerating at an exponential rate. As per Fortune Business Insights, the female contraceptive devices segment held nearly 54.8% of the overall market in the year 2017 and is expected to remain dominant over the forecast years.

With the advent of advanced technology, hormonal contraceptives are likely to lead the contraceptive devices market. This is mainly on account of their enhanced efficiency and rising preference among consumers. Governments in several countries are actively participating in the distribution of contraceptive devices across several hospitals. This further makes hospital pharmacies one of the leading sources for birth control devices.

Top Leaders Overview:
Some of the leading companies in the global Cardiovascular Stents Market are
• Bayer Pharmaceuticals
• Pfizer
• The Janssen Pharmaceutical Companies of John
• Teva Pharmaceuticals
• Merck
• Mylan
• Allergan
• RECKITT BENCKISER GROUP PLCVeru Inc.
• Medisafe® Medication Management Platform

The Global Contraceptive Devices Market derives growth from a number of factors such as increasing focus on research and development (R&D), increasing investment from leading companies towards R&D. Besides this, increasing regulatory approvals from organizations such as the Food and Drug Administration (FDA) have contributed significantly to the global Contraceptive Devices Market.
Furthermore, newer drug discoveries as a result of emphasis on R&D have favored the growth of the global Contraceptive Devices Market and are likely to boost the market in the coming years. Backed by contributions from government as well as private organizations, the global Contraceptive Devices Market is likely to gain traction in the coming years.

Request Customization of this Report@ https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/contraceptive-devices-market-100062

Lack of Proper Family Planning Will Fuel Demand for Contraceptive Devices
“The demand for contraceptive devices and drugs is likely to increase owing to the rising prevalence of STDs,” stated a lead analyst at FBI. These include injectable contraceptives, hormonal oral pills, and topical contraceptives. “This, coupled with the lack of family planning, drives the contraceptive devices market,” he added. Furthermore, unwanted pregnancies can have widespread implications.
This is further expected to increase the requirement of fertility control devices over the upcoming years. In addition to this, the rapid growth in population across the world is anticipated to enable contraceptives market witness accelerated gains. Several companies are increasing awareness on the use and safety of contraceptive devices. This is also considered as a growth factor driving the contraceptive devices market. These devices are preferred more as they offer a safer course of action. All the above factors are anticipated to witness promising growth in the contraceptive devices market between 2018 and 2025.
Among regions, North America is expected to remain dominant in the global contraceptive devices market throughout the forecast period. The rate of awareness among the population is high and the healthcare industry is well-established, thus making North America a leading region. On the other hand, Asia Pacific is also anticipated to offer considerable growth opportunities owing to sthe large population base and rising disposable income. In addition to this, the region is expected to witness significant growth with the rising awareness regarding the usage and benefits of contraceptives.

Adverse Effects of Contraceptives and their Limited Supply May Restrict the Market’s Growth
Although the use of contraceptives is increasing, there are some risks associated with the use of the same. These risks include infections which compe people to opt for permanent contraception methods. Also, there are millions of men and women who don’t use contraceptive devices owing to their limited supply. Not all countries have access to contraception, which limits the growth of the contraceptive devices market.

Initiatives by Several Players Aimed at Sustaining Competitive Advantage to Bode Well
Some of the key players present in the global contraceptives devices market are Janssen Pharmaceutical Company, Allergan plc, Veru Inc., Pfizer Inc., Teva Pharmaceuticals Industry, Mylan, Medisafe Distribution Inc., and Reckitt Benckiser plc. Several companies are taking initiatives to sustain in their competitiveness in the market for contraceptive devices. Furthermore, companies are creating awareness programs to encourage the use of contraceptives. These companies also provide different types of birth control devices at affordable rates to maintain their market share. For instance, Tera Pharmaceuticals in November 2017 signed an agreement with another company called CopperSurgical with an aim to acquire an intrauterine copper contraceptive called Paragard. Such strategies adopted by the leading players are expected to boost the global contraceptive devices market in the coming years.

Browse Complete Report Details @ https://www.fortunebusinessinsights.com/industry-reports/contraceptive-devices-market-100062

About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact us:

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Contraceptive Devices Market Growth? Prominent Players: Bayer Pharmaceuticals,Pfizer, The Janssen Pharmaceutical Companies of John, Teva Pharmaceuticals, Merck, Mylan,Allergan, RECKITT BENCKISER GROUP PLCVeru Inc., Medisafe® Medication here

News-ID: 1781845 • Views: 106

More Releases from Fortune Business Insights Pvt. Ltd.

Growth Dynamics on Coronary Stents Market 2020-2025| Key Players: Biotronik, Car …
The Global "Coronary Stents" Market is prognosticated to witness rapid growth in the coming years. In a report, titled, "Coronary Stents Market Size, Share and Global Trend By Deployment (Self and Balloon-expandable), Stent Type (Drug Eluting Stent, Bioresorbable Stent, Bare Metal Stent, Covered Stent and Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Catheterization Labs) and Geography Forecast till 2025" Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/coronary-stents-market-100065 Leading Players
Growth Dynamics on mHealth Apps Market 2020-2026| Key Players: Fitbit, Inc., App …
The global "mHealth apps market size 2020" is projected to reach USD 57.57 billion by 2026. Driven by the increasing number of novel product launches, the market will witness an impressive growth rate in the coming years. According to a report published by Fortune Business Insights, titled "mHealth Apps Market Size, Share & Industry Analysis, By App Type (Disease & Treatment Management, Wellness Management, Others), By Application (Monitoring Services, Fitness
What's driving the Electrophysiology Devices Market Growth? Prominent Players: A …
The global "electrophysiology devices" market size is projected to reach USD 10.51 billion by 2026. According to a report published by Fortune Business Insights, titled "Electrophysiology Devices Market Size, Share & Industry Analysis, By Type (Ablation Catheters, Diagnostic Catheters, Mapping Systems, Accessories & Others), By Application (Atrial Fibrillation, Supraventricular Tachycardia (SVT), Ventricular Tachycardia, and Others), By End User (Hospitals & ASCs, and Specialty Clinics & Diagnostic Centres), and Regional Forecast,
Growth Insight, Blood Glucose Monitoring Systems Market Size 2020 | North Americ …
As per the International Diabetes Foundation, the number of adults suffering from diabetes was around 425 million and is expected to reach 630 million by 2045. The prevalence of diabetes is primarily increasing owing to the rapid adoption of sedentary lifestyle and unhealthy food habits. This further shows that the demand for blood glucose monitoring systems will increase, thereby driving the global "blood glucose monitoring systems" market. Request a Sample Copy

All 5 Releases


More Releases for Contraceptive

Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Intrauterine Contraceptive Devices Market Future Opportunities 2025
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization.
Asia-Pacific Contraceptive Drugs Market Report 2017
The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you. In this report, the Asia-Pacific Contraceptive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request Sample Copy
Oral Contraceptive Pills Market: Regional & Competitive Analysis
According to TMR, the global oral contraceptive pills market is expected to be worth US$22.9 bn by 2023. On the basis of type, the position of combination oral contraceptive pill segment remains undisputed and is estimated to be worth US$18 bn by 2023. The segment is also identified as the fastest growing segment within the market. On the basis of category, the generic oral contraceptive pill segment will lead in
Intrauterine Contraceptive Devices (IUD) Market | Size | Analysis
Intrauterine devices (IUDs) are contraceptive medical implants used to avoid pregnancies for a long time period. IUD’S are also known as long-acting reversible contraceptive devices. An IUD is a T-shaped device which is made of flexible plastic along with a copper wire wrapped around its stem and is a reliable and safe method of sterilization for women. It is injected into the uterus, and their primary aim is to inhibit
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the